BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8535025)

  • 1. [Hypercalcemia and squamous cell carcinoma of the upper respiratory-digestive tracts. Incidence and prognosis].
    Degardin M; Nguyen M; Beaurin D; Lesoin A; Fournier C; Lefebvre JL; Cappelaere P
    Bull Cancer; 1995 Nov; 82(11):975-80. PubMed ID: 8535025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia in squamous cell carcinoma of the head and neck.
    Liaw CC; Huang JS; Wang JM; Ng KT
    J Formos Med Assoc; 1990 Jul; 89(7):548-53. PubMed ID: 1979596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of hypercalcemia in squamous cell carcinoma of the head and neck.
    Dorman EB; Yang H; Vaughan CW; Hong WK; Strong MS
    Head Neck Surg; 1984 Dec; 7(2):95-8. PubMed ID: 6511440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia in advanced head and neck squamous cell carcinoma: prevalence and potential impact on palliative care.
    Alsirafy SA; Sroor MY; Al-Shahri MZ
    J Support Oncol; 2009; 7(5):154-7. PubMed ID: 19831158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases.
    Penel N; Berthon C; Everard F; Neu JC; Clisant S; N'guyen M; Villet S; Fournier C; Lefebvre JL
    Oral Oncol; 2005 Oct; 41(9):884-9. PubMed ID: 16043379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia in patients with esophageal cancer.
    Geddes LG; Dorn RA; Wadleigh RG
    J Exp Clin Cancer Res; 1999 Mar; 18(1):61-2. PubMed ID: 10374679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and prognostic factors of malignancy-associated hypercalcemia in squamous cell carcinoma].
    Zhang SJ; Hu Y; Jiao SC; Liu ZF; Tao HT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):585-9. PubMed ID: 23286403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia related to the poor prognosis of patients with squamous cell carcinoma of the esophagus.
    Kuwano H; Baba H; Matsuda H; Ohno S; Mori M; Kanematsu T; Sugimachi K
    J Surg Oncol; 1989 Dec; 42(4):229-33. PubMed ID: 2593666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyercalcaemia in head and neck squamous cell carcinoma.
    Bradley PJ; Hoskin D
    Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):51-4. PubMed ID: 16552258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia in head and neck carcinoma. Incidence and prognosis.
    Won C; Decker DA; Drelichman A; Al-Sarraf M; Reed ML
    Cancer; 1983 Dec; 52(12):2261-3. PubMed ID: 6640497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia associated with parathyroid hormone-related protein at the terminal stage of uncomplicated squamous cell carcinoma in the head and neck region.
    Fujikawa M; Takata Y; Okamura K; Nakagawa M; Tateishi A; Kurokawa H; Sato K; Fukuda J; Kajiyama M; Fujishima M
    Head Neck; 2002 Jan; 24(1):56-62. PubMed ID: 11774403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia in epidermoid carcinoma of the head and neck.
    Goodwin WJ; Chandler JR
    Am J Surg; 1976 Oct; 132(4):444-8. PubMed ID: 65132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia in epidermoid tumors of the head and neck and esophagus.
    Stephens RL; Hansen HH; Muggia FM
    Cancer; 1973 Jun; 31(6):1487-91. PubMed ID: 4709963
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis.
    Le Tinier F; Vanhuyse M; Penel N; Dewas S; El-Bedoui S; Adenis A
    Int J Oral Maxillofac Surg; 2011 Sep; 40(9):938-42. PubMed ID: 21489752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary squamous cell carcinoma of the head and neck: a clinicopathologic series.
    Russell JO; Hoschar AP; Scharpf J
    Am J Otolaryngol; 2011; 32(6):557-63. PubMed ID: 21035908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of 64 patients with lung-cancer-associated hypercalcemia.
    Li X; Bie Z; Zhang Z; Li Y; Hu X; Liu W; Zhang S; Cheng G; Ai B
    J Cancer Res Ther; 2015 Nov; 11 Suppl():C275-9. PubMed ID: 26612452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of hypercalcemia in patients with lung cancer].
    Lazaretti-Castro M; Kayath M; Jamnik S; Santoro IL; Tadokoru H; Vieira JG
    Rev Assoc Med Bras (1992); 1993; 39(2):83-7. PubMed ID: 8242107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.